Research Article

Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors

Figure 1

Comparison of the KMO gene expression in CMTs. (a) KMO gene expression in benign (n = 30) and malignant CMT tissues (n = 54). (b) KMO gene expression in canine malignant CMTs at stages I/II/III (n = 37) and stages IV/V (n = 17). (P < 0.0001).

(a)
(b)